269
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Diabetes Complications and Related Comorbidities Impair the Accuracy of FreeStyle Libre, a Flash Continuous Glucose Monitoring System, in Patients with Type 2 Diabetes

ORCID Icon, , , , , , , & ORCID Icon show all
Pages 3437-3445 | Received 09 Jul 2022, Accepted 16 Sep 2022, Published online: 03 Nov 2022

References

  • Martin S, Schneider B, Heinemann L., et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271–278. doi:10.1007/s00125-005-0083-5
  • Shah VN, DuBose SN, Li Z, et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. J Clin Endocrinol Metab. 2019;104(10):4356–4364. doi:10.1210/jc.2018-02763
  • Ruan Y, Zhong J, Chen R, et al. Association of body fat percentage with time in range generated by continuous glucose monitoring during continuous subcutaneous insulin infusion therapy in type 2 diabetes. J Diabetes Res. 2021;2021:5551216. doi:10.1155/2021/5551216
  • Kan K, Zhu W, Lu F, et al. Contribution of structured self-monitoring of blood glucose to the glycemic control and the quality of life in both insulin- and noninsulin-treated patients with poorly controlled diabetes. Diabetes Technol Ther. 2017;19(12):707–714. doi:10.1089/dia.2017.0275
  • Malanda UL, Bot SD, Nijpels G. Self-monitoring of blood glucose in noninsulin-using type 2 diabetic patients: it is time to face the evidence. Diabetes Care. 2013;36(1):176–178. doi:10.2337/dc12-0831
  • Breton MD, Kovatchev BP. Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol. 2010;4(3):562–570. doi:10.1177/193229681000400309
  • Budiman ES, Samant N, Resch A. Clinical implications and economic impact of accuracy differences among commercially available blood glucose monitoring systems. J Diabetes Sci Technol. 2013;7(2):365–380. doi:10.1177/193229681300700213
  • Krouwer JS, Cembrowski GS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol. 2010;4(1):75–83. doi:10.1177/193229681000400110
  • Bonora B, Maran A, Ciciliot S, Avogaro A, Fadini GP. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes. J Endocrinol Invest. 2016;39(12):1391–1399. doi:10.1007/s40618-016-0495-8
  • Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178–1184. doi:10.2337/dc18-0166
  • Mancini G, Berioli MG, Santi E, et al. Flash glucose monitoring: a review of the literature with a special focus on type 1 diabetes. Nutrients. 2018;10(8):992. doi:10.3390/nu10080992
  • Elhadd T, Bashir M, Baager KA, et al. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study). Diabetes Res Clin Pract. 2021;172:108589. doi:10.1016/j.diabres.2020.108589
  • Wen X, Ou T, Zeng N, et al. Clinical interpretation of the flash continuous glucose monitoring data out of range in type 2 diabetes: a real-world study. Diabetes Res Clin Pract. 2021;178(8):108989. doi:10.1016/j.diabres.2021.108989
  • DuBois JA, Slingerland RJ, Fokkert M, et al. Bedside glucose monitoring-is it safe? A new, regulatory-compliant risk assessment evaluation protocol in critically ill patient care settings. Crit Care Med. 2017;45(4):567–574. doi:10.1097/CCM.0000000000002252
  • Pfutzner A, Klonoff DC, Pardo S, Parkes JL. Technical aspects of the Parkes error grid. J Diabetes Sci Technol. 2013;7(5):1275–1281. doi:10.1177/193229681300700517
  • Klonoff DC, Lias C, Vigersky R, et al. The surveillance error grid. J Diabetes Sci Technol. 2014;8(4):658–672. doi:10.1177/1932296814539589
  • Moser O, Eckstein ML, McCarthy O, et al. Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: a secondary outcome analysis of a randomized crossover trial. Diabetes Obes Metab. 2019;21(11):2505–2512. doi:10.1111/dom.13835
  • Olafsdottir AF, Attvall S, Sandgren U, et al. A clinical trial of the accuracy and treatment experience of the flash glucose monitor freestyle libre in adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):164–172. doi:10.1089/dia.2016.0392
  • Cao B, Wang R, Gong C, et al. An evaluation of the accuracy of a flash glucose monitoring system in children with diabetes in comparison with venous blood glucose. J Diabetes Res. 2019;2019:4845729. doi:10.1155/2019/4845729
  • Koschinsky T, Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev. 2001;17(2):113–123. doi:10.1002/dmrr.188
  • Bedini JL, Wallace JF, Pardo S, Petruschke T. Performance evaluation of three blood glucose monitoring systems using ISO 15197: 2013 accuracy criteria, consensus and surveillance error grid analyses, and insulin dosing error modeling in a hospital setting. J Diabetes Sci Technol. 2015;10(1):85–92. doi:10.1177/1932296815609368
  • Chandnani SR, Ramakrishna CD, Dave BA, Kothavade PS, Thakkar AS. A post-marketing surveillance study to evaluate performance of the EXIMO™ blood glucose monitoring system. J Clin Diagn Res. 2017;11(5):Fc29–fc32. doi:10.7860/jcdr/2017/26596.9892
  • Boulton AJ. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47(8):1343–1353. doi:10.1007/s00125-004-1463-y
  • Boulton AJM, Armstrong DG, Kirsner RS, et al. Diagnosis and management of diabetic foot complications. Compendia. 2018. doi:10.2337/db20182-1
  • Chaudhuri A, Umpierrez GE. Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. J Diabetes Complications. 2012;26(4):257–258. doi:10.1016/j.jdiacomp.2012.04.016
  • Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346(25):1954–1962. doi:10.1056/NEJMoa013591
  • Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res. 2009;335(1):165–189. doi:10.1007/s00441-008-0685-6
  • Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412–419. doi:10.1136/bmj.321.7258.412
  • Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57(5):891–897. doi:10.1161/hypertensionaha.110.162446
  • Toyoda M, Murata T, Saito N, et al. Assessment of the accuracy of an intermittent-scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study. Ther Apher Dial. 2021;25(5):586–594. doi:10.1111/1744-9987.13618
  • Reineke EL, Fletcher DJ, King LG, Drobatz KJ. Accuracy of a continuous glucose monitoring system in dogs and cats with diabetic ketoacidosis. J Vet Emerg Crit Care. 2010;20(3):303–312. doi:10.1111/j.1476-4431.2010.00538.x